Literature DB >> 32209831

How Should Rehabilitative Departments of Hospitals Prepare for Coronavirus Disease 2019?

Min Cheol Chang, Donghwi Park.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32209831      PMCID: PMC7253048          DOI: 10.1097/PHM.0000000000001428

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


× No keyword cloud information.
To the Editor: On March 11, 2020, the World Health Organization declared the coronavirus disease (COVID-19) a pandemic as it had spread to more than 100 countries worldwide. As can be observed in China and South Korea, COVID-19 caused by the novel coronavirus (2019-nCoV) will challenge the bed capacity, equipment, and healthcare staff of the rehabilitation department, as in other departments, like never before. According to previous reports, COVID-19 seems highly contagious, as seen in the case of infection in a church group and call center in South Korea.[1] Considering that 2019-nCoV is easily spread in a limited space, it can also be highly contagious during rehabilitation treatments because of the need for physical contacts and communications between the therapist and the patient. Against the massive influx of patients with COVID-19, how can we prepare to care for patients in need of rehabilitation treatments?

FREQUENT CHECKS FOR SYMPTOMS SUCH AS FEVER, COUGH, DYSPNEA, OR RHINORRHEA IN PATIENTS OR STAFF

The coronavirus disease is believed to be highly contagious and symptomatic, although silent transmission of asymptomatic cases has also been reported. Frequent symptom check in patients or medical staff before rehabilitation can minimize the spread of the virus in confined spaces such as physical therapy rooms.

MASK WEARING DURING TREATMENT

The novel coronavirus has been reported to spread through droplets and airborne transmission.[2,3] These two main routes of 2019-nCoV infections are categorized by particle size. Droplet infection is defined when large droplets that carry the infectious agent (>5 μm in diameter) become an infection source.[4] By contrast, airborne infection is defined when the infection usually occurs via the respiratory route, with the agent present in aerosols (infectious particles of <5 μm in diameter).[4] The droplets tend to be heavy and thus do not go far and stay around the patient (within 2 m of indoor air), mainly causing close-contact transmission. On the other hand, aerosols float through the air and can cause both long-distance contactless infections and close-contact transmission. Preliminary studies have shown that the main transmission route of 2019-nCoV is through respiratory droplets, although airborne transmission cannot be completely excluded. The size of coronavirus is approximately 0.12–0.15 μm[5]; thus, the 2019-nCoV is not easy to directly filter except with a mask such as N95, which has filtration efficiencies for most penetrating particles sized 0.1–0.3 μm.[6] However, wearing a mask such as a surgical or dental mask, as well as the N95 mask, has been reported to have an effect of blocking viral transmissions because the mask filters droplets or aerosols containing virus particles rather than the virus itself.[7] The surgical mask is also designed to filter 99.9% of aerosols of 3 μm in size that contain bacteria or viruses. Considering this, not only N95 masks but also surgical masks can also filter out all droplets that contain large amounts of viruses entering or leaving the respiratory tract and a significant amount of aerosols. Considering that a significant amount of viral penetration is required for virus infection, mask wearing for both the therapist and the patient during rehabilitation treatment is believed to show a reduction effect on the transmission of 2019-nCoV.

AVOIDING FACE-TO-FACE CONVERSATIONS BETWEEN MEDICAL STAFF AND PATIENTS

As seen in the 2019-nCoV infection cases in South Korea, droplets and aerosols, which are produced during conversations, prayers, and singing among people who sit densely in a limited space such as religious facilities like churches, seem to be the main cause of COVID-19 propagation. In addition, COVID-19 can also spread through having a meal and conversation together, as can be observed in many countries. Therefore, avoiding talking and having a meal together while facing each other not only between patients and medical staff but also among medical staff may help prevent the spread of COVID-19.

CHANGING THE REHABILITATIVE METHODS FOR PATIENTS WITH SYMPTOMS OR CONTACT HISTORY WITH COVID-19 PATIENTS

High false-negative rates in real-time polymerase chain reaction tests for 2019-nCoV have been reported.[8] Therefore, if the patient has symptoms or contact with a COVID-19 patient, careful observation and changing to bedside physical therapy in isolation for at least 2 weeks may be helpful in decreasing the COVID-19 propagation rate even if real-time polymerase chain reaction results are negative. The COVID-19 outbreak will cause many limitations in the rehabilitation department and other hospital facilities. Protocols for patient management and treatment plans for patients with COVID-19 in the rehabilitation department must begin in full force before the disease spreads further.
  9 in total

1.  Clinical Characteristics and Risk Factors Associated with Severe Disease Progression among COVID-19 Patients In Wad Medani Isolation Centers: A Multicenter Retrospective Cross-Sectional Study.

Authors:  Mohammed Yousif Elnaeem Yousif; Mohammed Mahmmoud Fadel Allah Eljack; Mazin S Haroun; Khabab Abbasher Hussien Mohamed Ahmed; Osman Amir; Mohammed Alfatih; Akram Khalid Al Tigany Al Shiekh; Mazin Abdelraham Osman Ahmed; Alshareef Nour; Radi Tofaha Alhusseini; Waddah Aljaely Mohammed Osman; Mohamed Abdulkarim; Mohammed Eltahier Abdalla Omer; Ibrahim M Mahgoub
Journal:  Health Sci Rep       Date:  2022-02-28

2.  People with Disabilities and Other Forms of Vulnerability to the COVID-19 Pandemic: Study Protocol for a Scoping Review and Thematic Analysis.

Authors:  Tiago S Jesus; Sureshkumar Kamalakannan; Sutanuka Bhattacharjya; Yelena Bogdanova; Juan Carlos Arango-Lasprilla; Jacob Bentley; Barbara E Gibson; Christina Papadimitriou
Journal:  Arch Rehabil Res Clin Transl       Date:  2020-08-20

3.  Risk factors for disease progression in COVID-19 patients.

Authors:  Min Cheol Chang; Yu-Kyung Park; Bong-Ok Kim; Donghwi Park
Journal:  BMC Infect Dis       Date:  2020-06-23       Impact factor: 3.090

4.  Considerations for Postacute Rehabilitation for Survivors of COVID-19.

Authors:  Lisa Mary Sheehy
Journal:  JMIR Public Health Surveill       Date:  2020-05-08

5.  Step-by-step inpatient rehabilitation for critical illness after coronavirus disease 2019: A CARE-compliant case report.

Authors:  Dae-Won Gwak; Jong-Moon Hwang
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

6.  Neurological diseases as mortality predictive factors for patients with COVID-19: a retrospective cohort study.

Authors:  Jong-Moon Hwang; Ju-Hyun Kim; Jin-Sung Park; Min Cheol Chang; Donghwi Park
Journal:  Neurol Sci       Date:  2020-07-08       Impact factor: 3.307

7.  Fasting Plasma Glucose Level Independently Predicts the Mortality of Patients with Coronavirus Disease 2019 Infection: A Multicenter, Retrospective Cohort Study.

Authors:  Min Cheol Chang; Jong-Moon Hwang; Jae-Han Jeon; Sang Gyu Kwak; Donghwi Park; Jun Sung Moon
Journal:  Endocrinol Metab (Seoul)       Date:  2020-08-26

Review 8.  Adaptations for rehabilitation services during the COVID-19 pandemic proposed by scientific organizations and rehabilitation professionals.

Authors:  Luz H Lugo-Agudelo; Kelly Mariana Cruz Sarmiento; Maria Alejandra Spir Brunal; Juan Carlos Velásquez Correa; Ana Maria Posada Borrero; Luisa Fernanda Mesa Franco; Rosarita Di Dio Castagna Ianini; Paola Andrea Ramírez Pérez Lis; Claudia Marcela Vélez; Daniel F Patiño Lugo; Christoph Gutenbrunner
Journal:  J Rehabil Med       Date:  2021-09-16       Impact factor: 2.912

9.  How Can Blockchain Help People in the Event of Pandemics Such as the COVID-19?

Authors:  Min Cheol Chang; Donghwi Park
Journal:  J Med Syst       Date:  2020-04-16       Impact factor: 4.460

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.